T.Man Pharmaceutical PCL (BKK:TMAN)
Thailand · Delayed Price · Currency is THB 11.30
-0.50 (-4.24%)
At close: May 11, 2026
T.Man Pharmaceutical PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 523.07 | 450.7 | 431.09 | 472.52 | 56.39 |
Depreciation & Amortization | 126.11 | 104.83 | 97.87 | 75.09 | 70.36 |
Loss (Gain) From Sale of Assets | -0.21 | -0.35 | -0.58 | 3.52 | 0.17 |
Asset Writedown & Restructuring Costs | 67.54 | 0.07 | 0.01 | - | - |
Provision & Write-off of Bad Debts | 5.93 | -3.29 | -44.63 | 40.57 | 11.64 |
Other Operating Activities | -41.6 | 21.27 | -66.84 | 101.77 | 16.04 |
Change in Accounts Receivable | -354.23 | 7.38 | -42.97 | -289.24 | -76.82 |
Change in Inventory | -112.36 | -59.79 | -125.25 | -62.83 | 101.77 |
Change in Accounts Payable | 90.58 | 34.98 | 3.49 | 65.99 | 101.17 |
Change in Unearned Revenue | 28.68 | -28.28 | 26.49 | - | - |
Change in Other Net Operating Assets | 2.94 | -7.85 | 3.41 | 116.13 | -5 |
Operating Cash Flow | 336.44 | 519.66 | 282.09 | 523.53 | 275.74 |
Operating Cash Flow Growth | -35.26% | 84.22% | -46.12% | 89.86% | 42.09% |
Capital Expenditures | -226.44 | -173.95 | -219.95 | -234.52 | -79.25 |
Sale of Property, Plant & Equipment | 0.21 | 1.09 | 2.33 | - | 1.21 |
Sale (Purchase) of Real Estate | - | - | - | 37.07 | - |
Investment in Securities | 297.7 | -650 | - | - | 5 |
Other Investing Activities | 59.65 | 1.83 | 1.24 | 20.08 | 0.05 |
Investing Cash Flow | 131.12 | -821.03 | -216.38 | -177.36 | -72.99 |
Short-Term Debt Issued | - | 929.11 | 28.81 | - | 19.61 |
Long-Term Debt Issued | - | - | - | 50 | - |
Total Debt Issued | - | 929.11 | 28.81 | 50 | 19.61 |
Short-Term Debt Repaid | -205 | -352.54 | -60.38 | -79.57 | -210.2 |
Long-Term Debt Repaid | -7.28 | -40.52 | -32.82 | -22.8 | -50.84 |
Total Debt Repaid | -212.28 | -393.06 | -93.2 | -102.37 | -261.04 |
Net Debt Issued (Repaid) | -212.28 | 536.05 | -64.4 | -52.37 | -241.43 |
Issuance of Common Stock | - | 1,164 | 59.13 | - | - |
Common Dividends Paid | -175.91 | -1,336 | -11.83 | - | - |
Other Financing Activities | -28.44 | -62.99 | -7.75 | -8.82 | -6.03 |
Financing Cash Flow | -416.63 | 301.72 | -24.85 | -61.19 | -247.46 |
Net Cash Flow | 50.93 | 0.35 | 40.86 | 284.98 | -44.71 |
Free Cash Flow | 110 | 345.71 | 62.15 | 289.02 | 196.49 |
Free Cash Flow Growth | -68.18% | 456.28% | -78.50% | 47.09% | 52.52% |
Free Cash Flow Margin | 4.35% | 15.53% | 3.14% | 14.27% | 15.55% |
Free Cash Flow Per Share | 0.28 | 1.01 | 0.23 | 1.16 | 2.72 |
Cash Interest Paid | 28.44 | 34.58 | 7.75 | 8.62 | 6.03 |
Cash Income Tax Paid | 74.54 | 77.68 | 164.55 | 50.32 | 14.53 |
Levered Free Cash Flow | -61.87 | 216.02 | -46.49 | 159.27 | 193.69 |
Unlevered Free Cash Flow | -44.1 | 227.66 | -37.2 | 169.88 | 198.18 |
Change in Working Capital | -344.39 | -53.57 | -134.83 | -169.95 | 121.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.